Contract HHSN268201400003I

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · Department Of Health And Human Services · September 25, 2024

Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)Full & Open CompetitionNAICS 541712

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 25, 2024 for an undisclosed amount of work in research and development in the physical, engineering, and life sciences (except biotechnology). It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on September 24, 2025. If all options are exercised, the contract could reach $15.46 million.

Potential value
$15.46M
if all options exercised
Modifications
1
Latest September 24, 2025

Contract details

PIID
HHSN268201400003I
Award type
Pricing
Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541712 · Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)
Product / service
Health R&D Services; Health Care Services; Basic Research
First action
September 25, 2024
Latest action
September 24, 2025

Description

IPP - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY

Modification timeline

  • September 24, 2025
    Mod P00010 · Supplemental Agreement For Work Within Scope
    $0
  • September 25, 2024
    Mod P00009 · Other Administrative Action
    $0

Similar contracts

RecipientAgencyDateObligated
Astrix Technology LlcDepartment Of Health And Human ServicesApril 1, 2026$235.0K
Astrix Technology LlcDepartment Of Health And Human ServicesApril 1, 2026$144.1K
Astrix Technology LlcDepartment Of Health And Human ServicesApril 1, 2026$559.9K
Advanced Bioscience Laboratories, Inc.Department Of Health And Human ServicesMarch 30, 2026$12.94M
Advanced Bioscience Laboratories, Inc.Department Of Health And Human ServicesMarch 30, 2026$0
Astrix Technology LlcDepartment Of Health And Human ServicesMarch 30, 2026$227.3K

Top contractors in NAICS 541712

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Brookhaven Science Associates Llc1$365.69M
2Northrop Grumman Systems Corporation1$162.00M
3Modern Technology Solutions, Inc.7$161.71M
4Aerojet Rocketdyne Of De, Inc1$160.86M
5Massachusetts Institute Of Technology21$153.36M
6Torch Technologies Inc7$90.25M
7Tecolote Research, Inc.24$83.32M
8Odyssey Systems Consulting Group, Ltd.4$80.71M
9Amentum Technology, Inc.14$62.57M
10Raytheon Company1$61.03M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSN268201400003I?

Contract HHSN268201400003I is a federal contract awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by Department Of Health And Human Services on September 25, 2024 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY). It has been modified 1 time since the base award.

Who won contract HHSN268201400003I?

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. won contract HHSN268201400003I from Department Of Health And Human Services.

How much is contract HHSN268201400003I worth?

Contract HHSN268201400003I has obligated $0 to date but carries a potential ceiling of $15.46 million if fully funded and all options are exercised.